Status
Conditions
Treatments
About
In this clinical trial we want to investigate the clinical benefit of a complementary therapy using therapeutical modalities of the traditional chinese medicine in patients suffering from advanced cancer.
Full description
After giving informed consent, the participants will be randomized into two groups (1:1). Both groups will receive standard care while one group will additionally be assigned to a practitioner of traditional Chinese medicine (TCM) who will deliver a individual treatment according to the needs of the participant (pragmatic approach).
Outcome measures will be monitored over the course of eight weeks.
Sex
Ages
Volunteers
Inclusion criteria
One of the following tumor entities
Best supportive care (i.e., no currently ongoing tumor-specific therapy)
o Exception: palliative anti-hormonal therapy or palliative radiotherapy
Performance status: ECOG 0 to 2
Estimated life expectancy > 4 months
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
0 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal